Performance analysis of hyperheuristics and their use with hill-climbers
2006
0 views
0 downloads
Advisor: Y.doç.dr. Ender Özcan
Abstract (EN)
Hyperheuristics are iterative approaches that are proposed as a higher level abstractionas compared to the metaheuristics. Hyperheuristic methods manage a set of heuristics forsolving a problem. A typical iteration in a hyperheuristic framework consists of two phases:heuristic selection and move acceptance. After the selection and application of an appropriateheuristic to a single candidate solution at hand, a decision is made whether to keep the newcandidate solution, or not. This decision is based on only nonproblem-specific data, such as,fitness change or heuristic execution time. In this thesis, the traditional framework is extendedand three new frameworks are proposed in order to make better use of hill-climbers. Theseframeworks and several heuristic selection method and acceptance criterion combinations areanalyzed in depth. Their performances are evaluated on well-known benchmark functions.The performance variances of the hyperheuristics are further investigated on the examinationtimetabling benchmark problem instances.
Author
Burak Bilgin
How to Cite
Burak Bilgin (Master Thesis). Performance analysis of hyperheuristics and their use with hill-climbers, 2006, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)